Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis
Key facts
- Where
- Kazan' and Moscow, RussiaSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 70 years old?
Source: NCT07375433, who can take part
Where in Russia
- Kazan State Medical UniversityKazan', RussiaTaking people
- National Medical Research Center for Therapy and Preventive MedicineMoscow, RussiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Medical Research Center for Therapy and Preventive Medicine
- Trial code
- NCT07375433
- Record updated
- 10 February 2026
- Original description
Study aim is comparison of heart failire with preserved ejection fraction (HFpEF) detection rate in patients with Сhronic Obstructive Pulmonary Disease (COPD) and the clinical course and prognosis in patients with COPD depending on HFpEF presence.Read full original descriptionShow less
Study aim is comparison of heart failire with preserved ejection fraction (HFpEF) detection rate in patients with Сhronic Obstructive Pulmonary Disease (COPD) and the clinical course and prognosis in patients with COPD depending on HFpEF presence.
Inclusion: Verified diagnosis of COPD; Patients hospitalized with COPD; Citizenship of the Russian Federation; Patients aged 50 to 70 years; Patient consent to participate in the study.
Exclusion: Any chronic diseases, other than COPD, that affect the prognosis, in the acute and/or decompensated stage; Mental disorders; Lack of Russian Federaion citizenship; Patient's refusal to participate in the study.